Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jérôme Thiéfaine
Institutions:
Cibles et Médicaments des Infections et de l'Immunité,
Nantes Université
Observed institutions:
Cibles et Médicaments des Infections et de l'Immunité,
Université de Nantes,
Nantes Université
ORCID:
0000-0002-6779-2829
Observed ORCID:
0000-0002-6779-2829
OpenAlex ID:
A5082409964
Investigating the C2 Modulation of the Imidazo[1,2‐ a ]pyrazine‐Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition
2024
·
Lhana Tisseur
, Sandrine Cojean
, et al.
·
ChemMedChem
·
7
Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases
2021
·
Viet Hung Dao
, Isabelle Ourliac-Garnier
, et al.
·
Molecules
·
7
PDF
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2- a ]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy
2025
·
Lhana Tisseur
, Cédric Logé
, et al.
·
RSC Medicinal Chemistry
·
4
5,6,7,8-Tetrahydroimidazo[1,2-a]pyrazine-based thiosemicarbazones as anti-Trypanosoma cruzi agents
2026
·
Marlene Saraiva de Araújo Neta
, Maísa Cavalcanti Coelho
, et al.
·
Bioorganic & Medicinal Chemistry
·
1
33rd GP2A Annual Medicinal Chemistry Conference, XIVth Paul Ehrlich MedChem Euro-PhD Network Meeting & COST Action One Health Drugs Against Parasitic Vector Borne Diseases in Europe and Beyond (OneHealthdrugs)
2026
·
Florence O. McCarthy
, Jean-Jacques Hélesbeux
, et al.
·
Drugs and Drug Candidates
Show more works
View as search
Works count:
5
Citation count:
19
H-index:
3
I10-index:
Year
Topic
Type